Need a report that reflects how COVID-19 has impacted this market and its growth?
The United Kingdom Contraceptive Devices Market is poised to grow at a CAGR of 8.01% over the forecast period.
The COVID-19 pandemic had impacted the growth of the studied market. Initially, the global COVID-19 outbreak and the lockdown scenario in the country have imposed some challenges on the market, as hospitals and clinics have suspended their services to prevent the spread of the SARS-CoV-2 virus. Also, the restrictions imposed by the government impacted the growth of the studied market. For instance, according to an article published in March 2022, titled ‘Effect of the COVID-19 pandemic on contraceptive prescribing in general practice: a retrospective analysis of English prescribing data between 2019 and 2020’, it has been observed that the use of long-acting contraceptives decreased, with implants by 76%, intrauterine systems by 79% and intrauterine devices by 76%. In addition, over the first three months of lockdown, the prescription for intrauterine and implant contraceptives was decreased by 75%, which led to increased unwanted pregnancies in the country. However, with resumed services and released COVID-19 restrictions the studied market is expected to grow over the forecast period.
Furthermore, as per a news published in October 2021, women were nine times more likely to experience access issues to contraception during the first lockdown, which led the proportion of unexpected births to nearly double, from 1.3% before the lockdown to 2.1% post lockdown. Hence, COVID-19 has had a significant impact on the market growth during the pandemic. However, with the releasing COVID-19 restrictions and resuming services, the demand for contraceptive devices is expected to increase over the forecast period.
Certain factors that are propelling the market growth are the increasing awareness of sexually transmitted diseases (STDs) and the rising rate of unintended pregnancies and the rise in government initiatives.
The imperative of reducing unplanned pregnancies and their consequences is the key factor driving the market growth in the United Kingdom. One of the major drivers for this demand is the need to prevent unwanted pregnancies, particularly among teenage women. For instance, according to the 2021 statistics published by the United Kingdom government, 214,256 abortions were reported in England and Wales in 2021. In addition, as per the same source, 89% of abortions were performed in women under 10 weeks in 2021 as compared to 88% in 2020. Thus, the rising number of abortions in the country is expected to increase the demand for contraceptive devices among the population, thereby propelling market growth.
However, the side effects associated with the use of contraceptive devices are likely to restrain the market growth over the forecast period.
Scope of the report
As per the scope of the report, contraceptive devices have been barriers that attempt to prevent pregnancy by physically preventing sperm from entering the uterus. Contraception is more commonly known as fertility, and birth control is described as the method used to avoid pregnancy. They include male condoms, female condoms, cervical caps, diaphragms, and contraceptive sponges with spermicide. The United Kingdom Contraceptive Devices Market is segmented by Type (Condoms, Diaphragms, Cervical Caps, Vaginal Rings, Intra Uterine Device (IUD), and Other Types) and Gender (Male and Female). The report offers the value (in USD million) for the above segments.
|Intra Uterine Device (IUD)|
Key Market Trends
Condoms are Expected to Dominate the United Kingdom Contraceptive Devices Market
The condom segment is expected to witness significant growth in the United Kingdom contraceptive devices market over the forecast period owing to the factors such as the rising adoption of condoms among the population and increasing awareness regarding sexually transmitted diseases in the country.
A condom is a barrier device in the shape of a sheath that is used during sexual activity to lower the risk of getting pregnant or contracting a sexually transmitted disease (STD).
According to the Government of United Kingdom data published in September 2021, the number of new cases of sexually transmitted infections in 2020 includes Chlamydia 161,672, Gonorrhoea 57,084, Herpes 20,530, Syphilis 6,926, Warts-27,473, Non-specific genital infection (NSGI) 15,705, Pelvic inflammatory disease (PID) and epididymitis 10,572. Such a high incidence of sexually transmitted infections in the United Kingdom is expected to drive market growth in this region due to the rise in the adoption of contraceptives in the United Kingdom.
Furthermore, according to the study titled 'Effects of a Novel Erectogenic Condom on Men and Women’s Sexual Pleasure: Randomized Controlled Trial' in published in January 2022 in the United Kingdom, CSD500, a novel condom appears to hold significant potential for its role as a condom that could improve men and women’s sexual pleasure. Such studies are expected to further drive this segment’s growth.
Moreover, according to the news published in February 2022, condom sales have shot up since lockdown restrictions eased in the United Kingdom. The rise in sales of condoms in the United Kingdom will further drive market growth in this region.
Therefore, owing to the above-mentioned factors, the market studied is expected to drive in the United Kingdom.
To understand key trends, Download Sample Report
The United Kingdom contraceptive devices market is moderately competitive. Some of the key industry contributors are AbbVie Inc. (Allergan), Bayer AG, Cooper Surgical Inc., and Pfizer, Reckitt Benckiser among others. Companies are undertaking strategic initiatives such as increasing investment in the research and development of innovative products to gain a competitive edge over generic products available in the market.
AbbVie Inc. (Allergan)
- In September 2022, Novo Nordisk launched over-the-counter hormone replacement therapy drug in the United Kingdom.
- In December 2021, Gedeon Richter UK Ltd became a marketing authorization holder (MAH) for Evra, a once-weekly transdermal contraceptive patch for women of fertile age in the United Kingdom.
Table of Contents
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Awareness about Sexually Transmitted Diseases (STDs)
4.2.2 Rising Rate of Unintended Pregnancies & Rise in Government Initiatives
4.3 Market Restraints
4.3.1 Side Effects Associated with the Use of Contraceptive Devices
4.4 Porter's Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Type
5.1.3 Cervical Caps
5.1.4 Vaginal Rings
5.1.5 Intra Uterine Device (IUD)
5.1.6 Other Types
5.2 By Gender
6. COMPETITIVE LANDSCAPE
*List Not Exhaustive
6.1 Company Profiles
6.1.1 AbbVie Inc. (Allergan)
6.1.2 Bayer AG
6.1.3 Cooper Surgical Inc.
6.1.4 Viatris (Mylan Laboratories)
6.1.5 Pfizer Inc.
6.1.6 Teva Pharmaceutical Industries Ltd
6.1.7 DKT International
6.1.8 Pregna International Limited
6.1.9 Reckitt Benckiser
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Frequently Asked Questions
What is the study period of this market?
The United Kingdom Contraceptive Devices Market market is studied from 2019 - 2027.
What is the growth rate of United Kingdom Contraceptive Devices Market?
The United Kingdom Contraceptive Devices Market is growing at a CAGR of 8.01% over the next 5 years.
Who are the key players in United Kingdom Contraceptive Devices Market?
CooperSurgical, Inc., AbbVie Inc. (Allergan), Pfizer Inc., Reckitt Benckiser, Bayer AG are the major companies operating in United Kingdom Contraceptive Devices Market.